Schrodinger, Inc. Logo

Schrodinger, Inc.

A physics-based computational platform for accelerated drug and materials discovery.

SDGR | NDAQ

Overview

Corporate Details

ISIN(s):
US80810D1037
LEI:
Country:
United States of America
Address:
1540 BROADWAY, 10036 NEW YORK
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Schrödinger, Inc. is a scientific technology company that provides an industry-leading, physics-based computational platform to accelerate molecular discovery. Its advanced software solutions are used by global biopharmaceutical, industrial, and academic organizations to design novel therapeutics and materials more rapidly and at a lower cost. The platform supports the entire discovery process, from target validation to lead optimization. In addition to its software business, Schrödinger leverages its technology to build a diverse pipeline of collaborative and proprietary drug discovery programs, aiming to develop innovative medicines for various diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Schrodinger, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Schrodinger, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Schrodinger, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
RELMADA THERAPEUTICS, INC. Logo
A clinical-stage biotech developing novel therapies for CNS diseases and oncology.
United States of America RLMD
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan 4889
Rentracks CO.,LTD. Logo
A pay-per-performance ad network with a closed ASP and comprehensive web consulting services.
Japan 6045
Replimune Group, Inc. Logo
Clinical-stage biotech developing oncolytic immunotherapies to treat a broad range of cancers.
United States of America REPL
ReproCELL Incorporated Logo
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
Japan 4978
RESEARCH FRONTIERS INC Logo
Develops and licenses smart glass tech for instant light, UV, and heat control.
United States of America REFR
Resolute Holdings Management, Inc. Logo
Asset management firm acquiring and operationally enhancing companies for long-term growth.
United States of America RHLD
Develops RNA aptamer therapeutics for ophthalmology, pain, fibrosis, and other unmet medical needs.
Japan 4591
Rise Consulting Group, Inc. Logo
Execution-focused consulting for strategy and digital transformation, specializing in JP-CN markets.
Japan 9168
ROQUEFORT THERAPEUTICS PLC Logo
Developing first-in-class, pre-clinical medicines for hard-to-treat cancers.
United Kingdom ROQ

Talk to a Data Expert

Have a question? We'll get back to you promptly.